The association of chemotherapy and radiotherapy: Biological rationale

Donatella Tirindelli Danesi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The combination of radiation and chemotherapy, based on a demonstrated preclinical rationale, has involved in the last decades the use of cytotoxic agents as radiosensitizers. Classic chemotherapeutic agents, such as 5-fluouracil and cisplatin, and more recently gemcitabine and taxanes, have been employed in different sequences with radiation therapy, even though the optimal combinations and scheduling are still in evolution. During recent years, due to the highly improved molecular understanding of intrinsic radioresistance and the profiling of cellular response to irradiation, a big effort exists in basic and translational research to identify novel treatment modalities combining radiation therapy with molecules that target very specific molecular pathways. © 2010 Bentham Science Publishers Ltd.
Original languageEnglish
Pages (from-to)152 - 156
Number of pages5
JournalCurrent Drug Therapy
Volume5
Issue number3
DOIs
Publication statusPublished - 2010
Externally publishedYes

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this